Zoetis (NYSE: ZTS)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Zoetis (NYSE: ZTS) through any online brokerage.
The latest price target for Zoetis (NYSE: ZTS) was reported by Goldman Sachs on Thursday, July 21, 2022. The analyst firm set a price target for 202.00 expecting ZTS to rise to within 12 months (a possible 15.74% upside). 9 analyst firms have reported ratings in the last year.
The stock price for Zoetis (NYSE: ZTS) is $174.53 last updated August 5, 2022, 8:00 PM UTC.
A quarterly cash dividend of $0.33 per share of Class A Common Stock. The quarterly cash dividend was payable on September 1, 2022 to stockholders of record on July 20, 2022.
Zoetis’s Q3 earnings are confirmed for Thursday, November 3, 2022.
There is no upcoming split for Zoetis.
Zoetis is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.